IMNN Imunon | $0.96 +0.0% | 1/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 1/24/2025 |
USEG U.S. Energy | $2.73 -9.6% | 1/24/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | Low | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/24/2025 |
URGN UroGen Pharma | $10.24 +0.9% | 1/23/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 1/23/2025 |
KAPA Kairos Pharma | $1.50 -3.8% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 1/22/2025 |
ANIX Anixa Biosciences | $2.82 -3.4% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 1/22/2025 |
CRMD CorMedix | $12.42 +1.0% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 1/22/2025 |
COYA Coya Therapeutics | $5.90 +1.0% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 1/21/2025 |
HUMA Humacyte | $4.61 +0.4% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Low | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 1/21/2025 |
RVPH Reviva Pharmaceuticals | $1.91 +1.1% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 1/21/2025 |
CXDO Crexendo | $5.67 -1.7% | 1/21/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $7.00 | High | View details for D. Boral Capital rating of Crexendo (NASDAQ:CXDO) on 1/21/2025 |
|
OMER Omeros | $8.37 -7.1% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | Medium | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 1/16/2025 |
IBRX ImmunityBio | $3.17 +1.6% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/16/2025 |
NOTE FiscalNote | $1.37 -5.9% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | High | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 1/16/2025 |
GOVX GeoVax Labs | $2.07 -3.3% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Low | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 1/16/2025 |
URGN UroGen Pharma | $10.24 +0.9% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 1/15/2025 |
OSTX OS Therapies | $2.69 -7.9% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 1/15/2025 |
HOVR New Horizon Aircraft | $0.81 -4.6% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | Medium | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 1/15/2025 |
CNTX Context Therapeutics | $0.90 -0.7% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 1/15/2025 |
ANIX Anixa Biosciences | $2.82 -3.4% | 1/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 1/14/2025 |
HUMA Humacyte | $4.61 +0.4% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 1/13/2025 |
CARM Carisma Therapeutics | $0.48 +7.7% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for D. Boral Capital rating of Carisma Therapeutics (NASDAQ:CARM) on 1/13/2025 |
AVXL Anavex Life Sciences | $10.49 +2.8% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | High | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/13/2025 |
CKPT Checkpoint Therapeutics | $3.00 +1.7% | 1/13/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $9.00 | Medium | View details for D. Boral Capital rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 1/13/2025 |
CRMD CorMedix | $12.42 +1.0% | 1/13/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $15.00 | Low | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 1/13/2025 |
USEG U.S. Energy | $2.73 -9.6% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | High | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/13/2025 |
CTSO Cytosorbents | $1.04 +1.0% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 1/13/2025 |
BMEA Biomea Fusion | $4.41 -1.6% | 1/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $128.00 -> $128.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 1/10/2025 |
IVVD Invivyd | $0.47 +13.1% | 1/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 1/10/2025 |
HOVR New Horizon Aircraft | $0.81 -4.6% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | Low | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 1/8/2025 |
VNRX VolitionRx | $0.62 -0.8% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 1/8/2025 |
CMPX Compass Therapeutics | $2.65 -14.5% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 1/8/2025 |
TRVI Trevi Therapeutics | $3.91 -2.0% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | Medium | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 1/8/2025 |
TTI TETRA Technologies | $4.60 -1.8% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.50 -> $5.50 | Medium | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 1/8/2025 |
RCEL AVITA Medical | $9.32 +4.1% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 1/8/2025 |
CTXR Citius Pharmaceuticals | $3.30 +4.8% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 1/7/2025 |
IMUX Immunic | $1.02 +2.8% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 1/7/2025 |
AREC American Resources | $0.75 +0.8% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for D. Boral Capital rating of American Resources (NASDAQ:AREC) on 1/7/2025 |
IBRX ImmunityBio | $3.17 +1.6% | 1/6/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/6/2025 |
NRXP NRx Pharmaceuticals | $3.22 +9.9% | 1/6/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 1/6/2025 |
NNOX Nano-X Imaging | $8.24 -5.8% | 1/6/2025 | Initiated by | D. Boral Capital | - | Buy | $23.00 | N/A | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 1/6/2025 |
Trillion-Dollar Crypto Play (Ad) Potential $20-trillion opportunity?
Put $500 into THIS AI Coin for 2025…
Click here to get the step-by-step guide… |
CTSO Cytosorbents | $1.04 +1.0% | 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 1/3/2025 |
LCTX Lineage Cell Therapeutics | $0.64 +1.0% | 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 1/3/2025 |
USEG U.S. Energy | $2.73 -9.6% | 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/3/2025 |
QNCX Quince Therapeutics | $1.59 -0.3% | 1/2/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 1/2/2025 |
NRXP NRx Pharmaceuticals | $3.22 +9.9% | 12/31/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 12/31/2024 |
HOVR New Horizon Aircraft | $0.81 -4.6% | 12/30/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 12/30/2024 |
CTXR Citius Pharmaceuticals | $3.30 +4.8% | 12/30/2024 | Upgraded by | D. Boral Capital | - | Hold -> Buy | $9.00 | N/A | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 12/30/2024 |
FBLG FibroBiologics | $1.68 +5.0% | 12/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 12/27/2024 |
RCEL AVITA Medical | $9.32 +4.1% | 12/24/2024 | Initiated by | D. Boral Capital | - | Buy | $25.00 | N/A | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 12/24/2024 |
AVXL Anavex Life Sciences | $10.49 +2.8% | 12/23/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $46.00 -> $46.00 | N/A | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 12/23/2024 |
CMPX Compass Therapeutics | $2.65 -14.5% | 12/23/2024 | Initiated by | D. Boral Capital | - | Buy | $32.00 | N/A | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 12/23/2024 |
OMER Omeros | $8.37 -7.1% | 12/23/2024 | Initiated by | D. Boral Capital | - | Buy | $36.00 | N/A | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 12/23/2024 |
IBRX ImmunityBio | $3.17 +1.6% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 12/20/2024 |
RZLV Rezolve AI | $2.87 -5.9% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for D. Boral Capital rating of Rezolve AI (NASDAQ:RZLV) on 12/20/2024 |
HUMA Humacyte | $4.61 +0.4% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 12/20/2024 |
IMNN Imunon | $0.96 +0.0% | 12/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 12/19/2024 |
CLNN Clene | $4.94 +2.7% | 12/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 12/19/2024 |
COYA Coya Therapeutics | $5.90 +1.0% | 12/18/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 12/18/2024 |
GOVX GeoVax Labs | $2.07 -3.3% | 12/18/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 12/18/2024 |
TTI TETRA Technologies | $4.60 -1.8% | 12/17/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.50 -> $5.50 | N/A | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 12/17/2024 |
BMEA Biomea Fusion | $4.41 -1.6% | 12/17/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $128.00 -> $128.00 | N/A | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 12/17/2024 |
ICFI ICF International | $123.41 -2.6% | 12/16/2024 | Reiterated by | D. Boral Capital | - | Outperform -> Outperform | $174.00 -> $174.00 | N/A | View details for D. Boral Capital rating of ICF International (NASDAQ:ICFI) on 12/16/2024 |
TRVI Trevi Therapeutics | $3.91 -2.0% | 12/12/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/12/2024 |
ENLV Enlivex Therapeutics | $1.18 -0.8% | 12/11/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 12/11/2024 |
CLNN Clene | $4.94 +2.7% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 12/10/2024 |
VNRX VolitionRx | $0.62 -0.8% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 12/10/2024 |
IMNN Imunon | $0.96 +0.0% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 12/10/2024 |
CRVO CervoMed | $2.31 +1.8% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Hold | | N/A | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 12/10/2024 |
BMEA Biomea Fusion | $4.41 -1.6% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $128.00 -> $128.00 | N/A | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 12/10/2024 |
CARM Carisma Therapeutics | $0.48 +7.7% | 12/9/2024 | Target Lowered by | D. Boral Capital | - | Buy -> Buy | $24.00 -> $12.00 | N/A | View details for D. Boral Capital rating of Carisma Therapeutics (NASDAQ:CARM) on 12/9/2024 |
URGN UroGen Pharma | $10.24 +0.9% | 12/6/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 12/6/2024 |
TRVI Trevi Therapeutics | $3.91 -2.0% | 12/4/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/4/2024 |
COYA Coya Therapeutics | $5.90 +1.0% | 12/4/2024 | Initiated by | D. Boral Capital | - | Buy | $15.00 | N/A | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 12/4/2024 |
ENLV Enlivex Therapeutics | $1.18 -0.8% | 12/3/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 12/3/2024 |
MNOV MediciNova | $1.89 -2.1% | 12/2/2024 | Initiated by | D. Boral Capital | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 12/2/2024 |
CRVO CervoMed | $2.31 +1.8% | 11/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $34.00 -> $34.00 | N/A | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 11/27/2024 |
CLGN CollPlant Biotechnologies | $3.77 -4.3% | 11/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 11/27/2024 |
AVXL Anavex Life Sciences | $10.49 +2.8% | 11/25/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $46.00 -> $46.00 | N/A | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 11/25/2024 |
IMNN Imunon | $0.96 +0.0% | 11/25/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 11/25/2024 |
GOVX GeoVax Labs | $2.07 -3.3% | 11/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 11/19/2024 |
ANIX Anixa Biosciences | $2.82 -3.4% | 11/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 11/19/2024 |
BMEA Biomea Fusion | $4.41 -1.6% | 11/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $128.00 -> $128.00 | N/A | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 11/19/2024 |
PED PEDEVCO | $0.85
| 11/20/2024 | Target Lowered by | D. Boral Capital | - | Buy -> Buy | $2.25 -> $1.50 | N/A | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 11/20/2024 |
FBLG FibroBiologics | $1.68 +5.0% | 11/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 11/20/2024 |
LCTX Lineage Cell Therapeutics | $0.64 +1.0% | 11/20/2024 | Target Lowered by | D. Boral Capital | - | Buy -> Buy | $3.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 11/20/2024 |
IVVD Invivyd | $0.47 +13.1% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 11/21/2024 |
HUMA Humacyte | $4.61 +0.4% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 11/21/2024 |
IBRX ImmunityBio | $3.17 +1.6% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 11/21/2024 |
AREC American Resources | $0.75 +0.8% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for D. Boral Capital rating of American Resources (NASDAQ:AREC) on 11/21/2024 |
CTXR Citius Pharmaceuticals | $3.30 +4.8% | 11/22/2024 | Reiterated by | D. Boral Capital | - | Buy -> Hold | | N/A | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 11/22/2024 |
Grab This Altcoin Before Trump's Crypto Announcement (Ad) The #1 Coin Poised to Soar Under Trump
Pro-Crypto White House could make this the investment opportunity of a lifetime!
Click HERE to access this free report before it's too late |
CNTX Context Therapeutics | $0.90 -0.7% | 11/25/2024 | Initiated by | D. Boral Capital | - | Buy | $9.00 | N/A | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 11/25/2024 |